Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioma | 22 | 2024 | 3491 | 2.940 |
Why?
|
Brain Neoplasms | 30 | 2024 | 9065 | 2.750 |
Why?
|
Central Nervous System Neoplasms | 9 | 2024 | 918 | 2.180 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2022 | 483 | 2.130 |
Why?
|
Ribonuclease III | 4 | 2022 | 271 | 1.250 |
Why?
|
Astrocytoma | 5 | 2023 | 772 | 1.200 |
Why?
|
DEAD-box RNA Helicases | 4 | 2022 | 386 | 1.160 |
Why?
|
Sarcoma, Clear Cell | 2 | 2023 | 73 | 0.990 |
Why?
|
Oncogene Proteins, Fusion | 9 | 2023 | 1609 | 0.880 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 4 | 2022 | 273 | 0.870 |
Why?
|
Choriocarcinoma | 1 | 2022 | 121 | 0.780 |
Why?
|
Germinoma | 1 | 2022 | 124 | 0.770 |
Why?
|
Transducin | 1 | 2020 | 42 | 0.720 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 5 | 2024 | 148 | 0.720 |
Why?
|
Sturge-Weber Syndrome | 5 | 2024 | 87 | 0.710 |
Why?
|
Receptor, trkB | 1 | 2020 | 124 | 0.660 |
Why?
|
Capillaries | 4 | 2024 | 751 | 0.640 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2018 | 19 | 0.620 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 124 | 0.610 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2023 | 2053 | 0.570 |
Why?
|
Infratentorial Neoplasms | 1 | 2018 | 94 | 0.570 |
Why?
|
RNA-Binding Protein EWS | 2 | 2021 | 211 | 0.540 |
Why?
|
Autopsy | 2 | 2020 | 1011 | 0.540 |
Why?
|
Gene Fusion | 3 | 2023 | 357 | 0.530 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2019 | 249 | 0.530 |
Why?
|
Myxoma | 1 | 2017 | 114 | 0.530 |
Why?
|
Child | 44 | 2024 | 80568 | 0.520 |
Why?
|
Histiocytoma, Malignant Fibrous | 3 | 2021 | 54 | 0.500 |
Why?
|
Retinoblastoma | 1 | 2018 | 316 | 0.500 |
Why?
|
Brain Stem Neoplasms | 3 | 2022 | 192 | 0.470 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 465 | 0.470 |
Why?
|
Neuroblastoma | 2 | 2024 | 1264 | 0.460 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 501 | 0.460 |
Why?
|
Child, Preschool | 28 | 2024 | 42510 | 0.460 |
Why?
|
Wilms Tumor | 1 | 2017 | 378 | 0.440 |
Why?
|
Ependymoma | 3 | 2021 | 310 | 0.420 |
Why?
|
Mutation | 25 | 2024 | 30192 | 0.420 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2014 | 147 | 0.420 |
Why?
|
Vascular Neoplasms | 1 | 2014 | 167 | 0.420 |
Why?
|
Sarcoma | 2 | 2022 | 1799 | 0.420 |
Why?
|
Histones | 4 | 2022 | 2590 | 0.410 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2024 | 3661 | 0.400 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2023 | 43 | 0.390 |
Why?
|
Repressor Proteins | 2 | 2021 | 2969 | 0.380 |
Why?
|
Hirschsprung Disease | 1 | 2013 | 164 | 0.380 |
Why?
|
Pituitary Gland, Anterior | 1 | 2012 | 142 | 0.380 |
Why?
|
Infant | 21 | 2024 | 36426 | 0.370 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2897 | 0.370 |
Why?
|
Proto-Oncogene Proteins | 3 | 2023 | 4520 | 0.370 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2012 | 169 | 0.350 |
Why?
|
Enteric Nervous System | 1 | 2013 | 213 | 0.350 |
Why?
|
Osteolysis | 1 | 2012 | 271 | 0.350 |
Why?
|
Adenoma, Oxyphilic | 1 | 2012 | 150 | 0.340 |
Why?
|
Rhabdoid Tumor | 2 | 2024 | 209 | 0.340 |
Why?
|
Prognosis | 12 | 2024 | 29890 | 0.330 |
Why?
|
Immunohistochemistry | 5 | 2023 | 11030 | 0.330 |
Why?
|
Adolescent | 26 | 2024 | 88811 | 0.330 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1882 | 0.330 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2024 | 954 | 0.330 |
Why?
|
Cell Transdifferentiation | 1 | 2010 | 186 | 0.320 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2017 | 2057 | 0.320 |
Why?
|
Death, Sudden | 2 | 2022 | 301 | 0.320 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2430 | 0.310 |
Why?
|
Rectum | 1 | 2013 | 895 | 0.310 |
Why?
|
Osteoclasts | 1 | 2012 | 713 | 0.300 |
Why?
|
Humans | 82 | 2024 | 765926 | 0.300 |
Why?
|
Glioblastoma | 4 | 2024 | 3458 | 0.300 |
Why?
|
Vascular Malformations | 3 | 2024 | 470 | 0.300 |
Why?
|
Medical Oncology | 1 | 2019 | 2339 | 0.290 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4882 | 0.290 |
Why?
|
Cerebellar Neoplasms | 2 | 2024 | 571 | 0.280 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2795 | 0.270 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1663 | 0.260 |
Why?
|
Young Adult | 19 | 2024 | 59857 | 0.250 |
Why?
|
Central Nervous System | 3 | 2022 | 1343 | 0.240 |
Why?
|
Hemangioma | 2 | 2021 | 724 | 0.240 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1433 | 0.230 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1996 | 0.230 |
Why?
|
Melanoma | 1 | 2023 | 5695 | 0.230 |
Why?
|
Neural Stem Cells | 1 | 2012 | 897 | 0.230 |
Why?
|
Male | 39 | 2024 | 363815 | 0.230 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1349 | 0.220 |
Why?
|
Receptor, EphB2 | 1 | 2023 | 31 | 0.220 |
Why?
|
Receptor, EphB4 | 1 | 2023 | 39 | 0.220 |
Why?
|
Encephalomyelitis, Equine | 1 | 2023 | 13 | 0.220 |
Why?
|
Encephalitis Virus, Eastern Equine | 1 | 2023 | 12 | 0.220 |
Why?
|
Calmodulin | 1 | 2024 | 240 | 0.220 |
Why?
|
Encephalitis, Viral | 1 | 2023 | 59 | 0.210 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2023 | 58 | 0.210 |
Why?
|
Pituitary Neoplasms | 1 | 2012 | 1322 | 0.210 |
Why?
|
West Nile virus | 1 | 2023 | 77 | 0.210 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 2036 | 0.210 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2023 | 88 | 0.210 |
Why?
|
Female | 39 | 2024 | 396141 | 0.200 |
Why?
|
Brain | 6 | 2024 | 27179 | 0.200 |
Why?
|
Soft Tissue Neoplasms | 2 | 2021 | 1163 | 0.200 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2022 | 45 | 0.200 |
Why?
|
Histiocytic Disorders, Malignant | 1 | 2022 | 14 | 0.200 |
Why?
|
Oncogene Fusion | 2 | 2019 | 84 | 0.190 |
Why?
|
Oligonucleotides, Antisense | 1 | 2024 | 462 | 0.190 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 432 | 0.180 |
Why?
|
Chordoma | 1 | 2024 | 343 | 0.180 |
Why?
|
Sudden Infant Death | 1 | 2024 | 293 | 0.180 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2023 | 257 | 0.180 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2021 | 64 | 0.180 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 184 | 0.180 |
Why?
|
Proteomics | 2 | 2024 | 3906 | 0.170 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 186 | 0.170 |
Why?
|
Encephalitis | 1 | 2024 | 440 | 0.170 |
Why?
|
Adult | 24 | 2024 | 223088 | 0.170 |
Why?
|
Chemokines | 1 | 2024 | 956 | 0.170 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 369 | 0.170 |
Why?
|
Lymphoproliferative Disorders | 1 | 2023 | 526 | 0.160 |
Why?
|
Neocortex | 1 | 2023 | 414 | 0.160 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2023 | 390 | 0.160 |
Why?
|
Language Development Disorders | 1 | 2020 | 194 | 0.160 |
Why?
|
Transcription Factors | 1 | 2018 | 12129 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12973 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9373 | 0.150 |
Why?
|
Frameshift Mutation | 1 | 2020 | 392 | 0.150 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 350 | 0.150 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 252 | 0.150 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 153 | 0.150 |
Why?
|
Mycoplasma hominis | 1 | 2017 | 10 | 0.150 |
Why?
|
Choroid Plexus Neoplasms | 1 | 2018 | 38 | 0.150 |
Why?
|
Neurons | 3 | 2020 | 9527 | 0.150 |
Why?
|
Methylation | 1 | 2020 | 1074 | 0.150 |
Why?
|
Oligodendroglioma | 1 | 2019 | 274 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 354 | 0.150 |
Why?
|
Choroid Neoplasms | 1 | 2019 | 175 | 0.140 |
Why?
|
Mycoplasma Infections | 1 | 2017 | 120 | 0.140 |
Why?
|
Neurofibromatosis 1 | 1 | 2022 | 561 | 0.140 |
Why?
|
Empyema, Pleural | 1 | 2017 | 60 | 0.140 |
Why?
|
Cytoplasm | 2 | 2012 | 1498 | 0.140 |
Why?
|
Endothelial Cells | 5 | 2024 | 3586 | 0.140 |
Why?
|
Ciliary Body | 1 | 2018 | 168 | 0.140 |
Why?
|
Translocation, Genetic | 1 | 2023 | 1393 | 0.140 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 640 | 0.140 |
Why?
|
Teratoma | 1 | 2020 | 402 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 615 | 0.140 |
Why?
|
Infant, Newborn | 6 | 2024 | 26380 | 0.140 |
Why?
|
Histone Demethylases | 1 | 2019 | 328 | 0.130 |
Why?
|
Arteriovenous Fistula | 1 | 2019 | 318 | 0.130 |
Why?
|
Choroid | 1 | 2019 | 351 | 0.130 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2019 | 360 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2024 | 976 | 0.130 |
Why?
|
Lysine | 1 | 2020 | 993 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1142 | 0.130 |
Why?
|
Aneuploidy | 1 | 2019 | 576 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 704 | 0.120 |
Why?
|
Myocytes, Cardiac | 1 | 2024 | 1672 | 0.120 |
Why?
|
Neural Tube Defects | 1 | 2017 | 256 | 0.120 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4111 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2024 | 81537 | 0.120 |
Why?
|
Medulloblastoma | 1 | 2020 | 657 | 0.120 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2018 | 335 | 0.120 |
Why?
|
Pathology, Molecular | 1 | 2018 | 329 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 519 | 0.120 |
Why?
|
Cell Differentiation | 4 | 2023 | 11639 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2019 | 779 | 0.120 |
Why?
|
Age of Onset | 1 | 2021 | 3343 | 0.110 |
Why?
|
Biomedical Research | 2 | 2020 | 3458 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2020 | 1272 | 0.110 |
Why?
|
Middle Aged | 15 | 2024 | 223016 | 0.110 |
Why?
|
Skull | 1 | 2017 | 818 | 0.100 |
Why?
|
Meningioma | 1 | 2021 | 1221 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8603 | 0.100 |
Why?
|
Horses | 2 | 2023 | 294 | 0.100 |
Why?
|
Texas | 1 | 2013 | 410 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1252 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 998 | 0.100 |
Why?
|
Sequence Analysis, DNA | 3 | 2020 | 4780 | 0.100 |
Why?
|
Genomics | 4 | 2024 | 5925 | 0.100 |
Why?
|
Survival Analysis | 2 | 2021 | 10086 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1763 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5691 | 0.090 |
Why?
|
Aged | 9 | 2024 | 171163 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2814 | 0.090 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2012 | 42 | 0.090 |
Why?
|
Cervical Vertebrae | 1 | 2017 | 978 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2627 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6503 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3715 | 0.090 |
Why?
|
NF-kappa B | 1 | 2019 | 2492 | 0.090 |
Why?
|
Skin | 1 | 2024 | 4481 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2603 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2012 | 307 | 0.090 |
Why?
|
Pyrimidines | 1 | 2022 | 3049 | 0.090 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2012 | 249 | 0.080 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2019 | 5752 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9600 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2014 | 1835 | 0.080 |
Why?
|
Astrocytes | 1 | 2017 | 1346 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1117 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2012 | 506 | 0.080 |
Why?
|
Coronary Thrombosis | 1 | 2012 | 440 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2536 | 0.080 |
Why?
|
Biopsy | 3 | 2020 | 6766 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 683 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2045 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2017 | 1311 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4394 | 0.070 |
Why?
|
Epilepsy | 1 | 2023 | 3317 | 0.070 |
Why?
|
Age Factors | 2 | 2024 | 18382 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2012 | 1072 | 0.070 |
Why?
|
Thalidomide | 1 | 2012 | 886 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1541 | 0.070 |
Why?
|
Pediatrics | 1 | 2022 | 3609 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39228 | 0.070 |
Why?
|
Losartan | 1 | 2008 | 263 | 0.070 |
Why?
|
Cholangiocarcinoma | 1 | 2012 | 577 | 0.070 |
Why?
|
Bile Duct Neoplasms | 1 | 2012 | 624 | 0.060 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3940 | 0.060 |
Why?
|
Enalapril | 1 | 2008 | 317 | 0.060 |
Why?
|
Glomerulonephritis | 1 | 2008 | 331 | 0.060 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18292 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13631 | 0.060 |
Why?
|
Drug-Eluting Stents | 1 | 2012 | 680 | 0.060 |
Why?
|
Mice | 9 | 2024 | 81782 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 428 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5333 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2019 | 16039 | 0.060 |
Why?
|
RNA, Viral | 2 | 2023 | 2866 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1721 | 0.060 |
Why?
|
Animals | 12 | 2024 | 168735 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4278 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 5994 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13614 | 0.060 |
Why?
|
Neopterin | 1 | 2024 | 57 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2024 | 22228 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3788 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2012 | 2864 | 0.050 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 3816 | 0.050 |
Why?
|
Pancreas | 1 | 2010 | 1698 | 0.050 |
Why?
|
Neoplasms | 2 | 2024 | 22340 | 0.050 |
Why?
|
Renin-Angiotensin System | 1 | 2008 | 736 | 0.050 |
Why?
|
Claudins | 1 | 2024 | 118 | 0.050 |
Why?
|
Cell Membrane | 1 | 2012 | 3635 | 0.050 |
Why?
|
Preoperative Care | 1 | 2012 | 2248 | 0.050 |
Why?
|
Survival Rate | 3 | 2024 | 12822 | 0.050 |
Why?
|
Uridine | 1 | 2022 | 135 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2024 | 2823 | 0.050 |
Why?
|
Phospholipase C beta | 1 | 2021 | 48 | 0.050 |
Why?
|
RNA, Double-Stranded | 1 | 2023 | 292 | 0.050 |
Why?
|
Signal Transduction | 3 | 2021 | 23597 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3604 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2012 | 1961 | 0.050 |
Why?
|
Vesicular Transport Proteins | 1 | 2024 | 376 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1513 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 17060 | 0.040 |
Why?
|
Phosphorylation | 1 | 2012 | 8279 | 0.040 |
Why?
|
Methionine | 1 | 2022 | 569 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 634 | 0.040 |
Why?
|
Long QT Syndrome | 1 | 2024 | 474 | 0.040 |
Why?
|
Liver Transplantation | 1 | 2012 | 2418 | 0.040 |
Why?
|
Facies | 1 | 2020 | 223 | 0.040 |
Why?
|
Codon | 1 | 2021 | 599 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 183 | 0.040 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2019 | 108 | 0.040 |
Why?
|
Chromatin | 2 | 2022 | 2979 | 0.040 |
Why?
|
Phenotype | 3 | 2022 | 16714 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 869 | 0.040 |
Why?
|
Brain Stem | 1 | 2024 | 854 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 160 | 0.040 |
Why?
|
Chromosomal Instability | 1 | 2019 | 175 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 186 | 0.040 |
Why?
|
Pons | 1 | 2019 | 239 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2023 | 1239 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2022 | 1494 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2019 | 425 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59496 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 428 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
Homozygote | 1 | 2022 | 1774 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5782 | 0.040 |
Why?
|
Neurosurgical Procedures | 2 | 2019 | 2077 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18074 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15401 | 0.030 |
Why?
|
Decompressive Craniectomy | 1 | 2017 | 76 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2021 | 1202 | 0.030 |
Why?
|
Action Potentials | 1 | 2024 | 1837 | 0.030 |
Why?
|
DNA Methylation | 2 | 2022 | 4424 | 0.030 |
Why?
|
Laminectomy | 1 | 2017 | 227 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21069 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 614 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1226 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 474 | 0.030 |
Why?
|
Epigenomics | 1 | 2021 | 958 | 0.030 |
Why?
|
Insulin | 1 | 2010 | 6603 | 0.030 |
Why?
|
Phylogeny | 1 | 2023 | 2837 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1232 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1621 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2393 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3608 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2019 | 714 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1601 | 0.030 |
Why?
|
Glycoproteins | 1 | 2022 | 2196 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1384 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2017 | 913 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1777 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2423 | 0.030 |
Why?
|
RNA | 1 | 2024 | 2716 | 0.030 |
Why?
|
Recurrence | 2 | 2019 | 8492 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 18962 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2510 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3623 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1213 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3599 | 0.030 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1884 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4130 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2017 | 865 | 0.020 |
Why?
|
Bone Marrow Examination | 1 | 2012 | 155 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2022 | 1657 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3542 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1966 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.020 |
Why?
|
Hippocampus | 1 | 2023 | 3772 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2744 | 0.020 |
Why?
|
Massachusetts | 1 | 2023 | 8882 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4859 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11196 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6058 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5772 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14450 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7417 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5190 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36547 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8037 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2895 | 0.020 |
Why?
|
Hepatitis B, Chronic | 1 | 2012 | 413 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3594 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4443 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5880 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9351 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9541 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2111 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10426 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20133 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6306 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2012 | 4498 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 2769 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22327 | 0.010 |
Why?
|
Blood Glucose | 1 | 2014 | 6422 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10843 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 65194 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41680 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54807 | 0.010 |
Why?
|